로딩 중…
지수 로딩 중…
킵스파마
256940· KOSDAQ· Information Technology· Semiconductors & Semiconductor Equipment
₩6,090-1.93%
2026-06-19
Price Chart
킵스파마-69.70%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 122.28B KRW |
| Revenue | 188.94B KRW |
| Net Income | -3.25B KRW |
| Total Assets | 243.88B KRW |
| Net Assets | 85.23B KRW |
| Employees | 27 |
| Value | |
| P/B | 1.43x |
| P/S | 0.65x |
| EV/EBITDA | 233.75x |
| FCF Yield | -38.32% |
| Profitability | |
| ROE | -3.81% |
| ROA | -1.33% |
| Op. Margin | 0.43% |
| Revenue Growth | 46.23% |
| Earnings Growth | -744.19% |
| Financial Health | |
| Debt Ratio | 286.14% |
| Total Debt | 92.11B KRW |
| FCF | -46.85B KRW |
| Cash | 22.30B KRW |
| Current Ratio | 1.26x |
| Net Debt/EBITDA | 84.95x |
| Performance | |
| 1Y Return | -69.70% |
| 1M Return | 2.18% |
| From 52W High | -72.51% |
| 1Y MDD | -71.65% |
| Trading | |
| Volume | 49,846 shares |
| Foreign Own. | 2.42% |
| Per Share | |
| EPS | -120 KRW |
| BPS | 3,319 KRW |
Company Info
KeepsPharma, established in 2000 and headquartered in Hwaseong-si, Gyeonggi-do, transitioned to the pharmaceutical and biotechnology sector in 2025, following its KOSDAQ listing in 2017. The company's primary activities include the manufacturing and sales of specialized medicines, development of oral peptide drug delivery platforms, anticancer treatments, and medical devices. KeepsPharma is also diversifying its business through the expansion of CDMO and CMO services, LFP recycling, and the localization of micro OLED equipment and fine metal masks.